Search Results 1691-1700 of 20659 for Informed consent

1. Veliparib with or without Carboplatin in Treating Patients with Stage III or Stage IV Breast Cancer - Mayo Clinic

   ... inform her treating physician immediately; Ability to understand and the willingness to sign a written informed consent document. Exclusion Criteria: Prior ...

2. Screening For Pregnancy Related Heart Failure In Nigeria - Mayo Clinic

   - Willing and able to provide informed consent. Exclusion Criteria: - Complex congenital heart disease (single ventricle physiology or significant shunts

3. Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival - Mayo Clinic

   Must provide study-specific informed consent prior to study entry. Exclusion Criteria: Pathologic evidence of local/regional breast tumor recurrence. Co ...

4. Dynamic Evaluation Of Spinal Alignment And Balance In Adults With Spinal Deformity Using Momentum Spine - Mayo Clinic

   Additionally, those who cannot provide informed consent due to cognitive impairment or language barriers beyond available resources will not be eligible.

5. Analysis of Biomarkers in Type 1 Diabetes Mellitus - Mayo Clinic

   Capable of providing informed consent. Exclusion Criteria: eGFR ≤ 60 ml/mt; Pregnancy. Participating Mayo Clinic locations. Study statuses change often. Please ...

6. Nivolumab With or Without Ipilimumab in Treating Patients With Refractory Metastatic Anal Canal Cancer - Mayo Clinic

   ... informed consent form documenting this discussion; the effects ... Ability to understand and the willingness to sign a written informed consent document - ...

7. PET imaging with [18F]BF4 - Clinical Trials

   Subjects must provide written informed consent. Agree to provide biopsy of tumor indicated on PET for research purposes, if accessible. Endometrial Cancer ...

8. A Study Of Gallium-68-labeled Fibroblast Activation Protein Inhibitor-46 (68Ga-FAPI-46) PET In Crohn’s Disease Patients - Mayo Clinic

   Subjects with the capacity to give informed consent and willingness to provide a written consent as well as willingness to answer a standardized symptom ...

9. A Study of High Dose Nicotine Patch Therapy for Smokeless Tobacco Users - Mayo Clinic

   Have been provided with, understand, and have signed the informed consent. Exclusion Criteria. Currently using (past 30 days) any other behavioral or ...

10. A Study to Assess the Effectiveness of Osimertinib Plus Savolitinib in Patients with Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Progressed Following Osimertinib Treatment (SAVANNAH Study) Following Prior Osimertinib - Mayo Clinic

    Participation eligibility · Patients must be ≥ 18 years of age (≥ 20 years of age in Japan). · Capable of giving signed informed consent which includes ...